Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How do you distinguish pseudodementia from early Alzheimer's diease with comorbid depression?
Related Questions
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
How do you approach the psychiatric symptom management of Huntington’s Disease?
What medications do you prioritize or avoid in Parkinson’s Disease-related psychosis and behavioral disturbance?
Is a history of coronary artery disease and afib a contraindication to using donepezil?
What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?
How do you treat extrapyramidal symptoms secondary to anti-psychotic use in patients who have not benefited from cogentin or benadryl?
When do you evaluate patients with Parkinson's disease and cognitive decline for concurrent Alzheimer's disease?
What would prompt discontinuing treatment versus switching or sequencing treatment in patients treated with an anti-amyloid therapy for Alzheimer's?
How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
